Wagner Wealth Management (South Carolina)’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-230
Closed -$46K 648
2021
Q2
$46K Sell
230
-210
-48% -$39.1K 0.03% 261
2021
Q1
$77K Sell
440
-30
-6% -$5.42K 0.06% 194
2020
Q4
$80K Buy
+470
New +$77.4K 0.08% 125

Other funds holding BBH

Wagner Wealth Management (South Carolina)'s BBH Position: Q3 2021 in Review

Wagner Wealth Management (South Carolina) sold out of VanEck Biotech ETF (BBH) in Q3 2021, closing a stake of 230 shares — an estimated $46K sold.

Wagner Wealth Management (South Carolina) first reported a position in BBH in Q4 2020 and held it in 3 quarters. The position peaked at $80K in Q4 2020. 118 funds tracked by Wall St. Rank hold BBH as of Q3 2021.

  • Wagner Wealth Management (South Carolina) reported no remaining VanEck Biotech ETF position as of Q3 2021 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 230 VanEck Biotech ETF shares in Q3 2021, an estimated $46K.
  • Wagner Wealth Management (South Carolina) first reported a position in VanEck Biotech ETF in Q4 2020 and held it in 3 quarters.
  • Wagner Wealth Management (South Carolina)'s VanEck Biotech ETF position peaked at $80K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2021.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2021, filed 15 Nov 2021.